Company Filing History:
Years Active: 2019-2024
Title: The Innovations of Robert Donaldson
Introduction
Robert Donaldson is a notable inventor based in Southborough, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compositions and methods for producing recombinant proteins. With a total of 5 patents to his name, Donaldson's work has had a substantial impact on medical research and therapeutic applications.
Latest Patents
Among his latest patents, one focuses on "Compositions and methods for producing a composition." This invention provides mammalian cells capable of producing recombinant CTLA4-Ig and its variants. It also details the compositions comprising CTLA4-Ig and formulations thereof. Furthermore, the invention outlines methods for mass-producing CTLA4-Ig from mammalian cells and for purifying the CTLA4-Ig. Another patent addresses the "Carbohydrate content of CTLA4 molecules," reiterating the capabilities of mammalian cells in producing recombinant CTLA4-Ig and its variants, along with the associated compositions and purification methods.
Career Highlights
Robert Donaldson is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to advancements in biotechnology. His work is pivotal in the development of therapeutic proteins that can enhance treatment options for various diseases.
Collaborations
Donaldson has collaborated with esteemed colleagues such as Kirk J. Leister and Eugene J. Schaefer, further enriching his research and development efforts.
Conclusion
Robert Donaldson's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of important therapeutic solutions.